A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Recruiting

Phase 1

Phase 2

ALN-4324A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Sponsor:

Alnylam Pharmaceuticals

Code:

NCT06845202

Conditions

Obese or Overweight Healthy Volunteers

Type 2 Diabetes Mellitus (T2DM)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

ALN-4324

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Alnylam Pharmaceuticals on 2025-10-20.